A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

Clinical trial NCT00802594 · COMPLETED

Trial details

NCT number: NCT00802594
Sponsor: Immtech Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Trypanosomiasis, African

Start date: 2001-08-01
Primary completion: 2002-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.